Daniel Prins

Daniel Prins is a seasoned professional in clinical research with extensive experience in managing global clinical trials, specializing in Hematology. Currently serving as Global Study Associate Director at Acerta Pharma B.V., a member of the AstraZeneca Group, Daniel orchestrates complex global studies, guiding a team of global study managers and ensuring compliance with regulatory guidelines. Previous roles include Senior Project Manager at ICON plc and PRA Health Sciences, where Daniel managed Phase I studies for Bayer AG. Daniel's experience also encompasses project management at UMC Utrecht and QPS Netherlands B.V., along with a solid educational background in Human Movement Sciences from the University of Groningen.